Analyst Coverage



INVESTOR RELATIONS
Firm Analyst
Punk, Ziegel & Company   Matthew L. Kaplan
Needham & Company   Mark Monane

Sonus Pharmaceuticals, Inc is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding Sonus Pharmaceuticals, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Sonus Pharmaceuticals, Inc or its management. Sonus Pharmaceuticals, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.



  • Stock Information
Ticker: SNUS
Exchange: NASD
Last Price: 0.33
Change: up 0.01
Volume: 264,400